Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

Tofacitinib is an effective and safe treatment for alopecia areata.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Better documentation of alopecia areata in Black individuals is needed to improve diagnosis.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

The UK's EDS National Diagnostic Service found that early diagnosis, lifestyle advice, and regular check-ups are crucial for managing vascular Ehlers-Danlos syndrome. A combination of losartan and bisoprolol can reduce vascular events, improving survival and quality of life.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Low-dose intralesional corticosteroid treatment led to rapid hair regrowth in localized alopecia areata.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Oral tofacitinib is more effective than oral minoxidil for treating alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.